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ABSTRACT 
Objective: This report aimed to determine the immediate effect of the IPC training on the knowledge and role of patent medicine vendors (PMV) in 
the COVID-19 outbreak response in Nigeria. 
Methods: We conducted a quasi-experimental study before and after the IPC training among 1076 PMV in Ilorin, Kwara state, Nigeria. Data analysis 
was done using SPSS version 23. Eight questions were asked, for which each was assigned a score of “1”. Participants who had scored<50% were 
categorized as “Fail”, while those with scores ≥50% were categorized as “Pass” in both the pre and post -tests. The Chi-square test was used to test 
for the association between sociodemographic characteristics and performance of respondents in the pre-and post-IPC knowledge results, and 
paired t-test to test for significant differences between the pre and post-tests mean scores. The level of significance was set at p<0.05 for all 
statistical tests. 
Results: The mean age of the 1076 respondents was 37.06±10.96, 463(43%) passed the pre-test, while 617 (57.3%) passed the post-test. The mean 
pre-test IPC training score was 3.1310±1.5631, while the mean post-test IPC training score was 3.7351±1.6028 (t=-11.337, p=<0.001). In all, 
617(57.3%) scored higher in posttest. Overall, 560 (92.41%) identified community sensitization and health education on COVID-19 preventive 
measures as roles of PMV. 
Conclusion: Regular trainings on COVID-19 preventive practices among PMV should be conducted. PMV should be empowered to sensitize and 
educate their clients on the prevention of COVID-19.  
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INTRODUCTION 
The Coronavirus (COVID-19) pandemic has necessitated a change in 
the delivery of health services from the traditional manner of care-
seeking from hospitals only [1-3]. Care-seeking for both emergency 
and non-emergency cases during the COVID-19 outbreak has placed 
an increased burden on healthcare workers and health facilities [1, 
2, 4]. Of the 48,171,563 COVID-19 cases globally, Africa accounts for 
nearly 0.13% and 63328 cases have been recorded in Nigeria as of 
5th November 2020, and health facilities are becoming inadequate 
in managing patients [5]. The gross inadequacy of the health 
facilities has therefore posited that the available human resources 
for health is insufficient to cater for the teeming population of nearly 
206 million population of Nigeria [6]. Prior to the COVID-19 
pandemic, Nigeria’s health workforce was estimated at 2.23 per 
1000 population, a value which falls below the 4.45 health 
workforce per 1000 population recommended by the World Health 
Organization [7]. The shortage of health manpower has persisted 
into the COVID-19 context and promoted navigation towards home-
based care of COVID-19 cases [8]. This array of evidence therefore 
necessitates a response from the private or public sector, formal or 
informal, for an improved response during the COVID-19 pandemic. 
In this regard, the roles of patent medicine vendors (PMV) cannot be 
over-emphasized.  
The PMV are key informal providers of healthcare in communities in 
developing countries [9-11]. In Nigeria, PMV has contributed to the 
reduction in malarial burden, childhood diarrhea, and the 
enhancement of health education and promotion, infection 
prevention, and control practices at community levels, and boost 
linkage to the national health system when required [11-13]. 
Building on these successes, PMV occupy a focal point for tackling 
the COVID-19 pandemic at the community level [14]. The increasing 
community-wide transmission of COVID-19 further approves of the 
need to engage PMV in the COVID-19 response strategy [15]. To the 
best of our knowledge, no study has been conducted in Nigeria on 
the role of PMV in the COVID-19 response. A study of this regard 
would be important in the implementation of a national plan to 
deliver quality-assured community-centered health service in the 
COVID-19 response through the inclusion of PMV. Therefore, this 
study aimed to assess the roles of PMV in the COVID-19 response in 
a North-Central State in Nigeria. 
MATERIALS AND METHODS 
Study area 
Kwara state, one of the 36 states in Nigeria, was created in 1967 
when 12 states were created from Nigeria by the military 
government. Kwara state occupies 33,433kilometre square land 
area and is made up of more than 100 towns and villages [16]. 
Kwara state is bounded by Benin to the West, Kogi to the East, Ekiti, 
Osun, and Oyo to the South, and Niger state to the North. Kwara 
State is administratively organized at the state and LGA levels with 
16 LGAs [17, 18]. Patent medicine stores are readily available across 
the LGA in Kwara state. Ethical approval for the study was obtained 
from the Institutional Review Board of the National Institute of 
Medical Research, Lagos, Nigeria (Ref No: IRB/20/048). 
Study population 
The participants were 1076 PMV from 14 out of the 16 LGAs in Kwara 
State. The enrolled LGAs included: Ilorin South, Ilorin East, Irepodun, 
Ilorin West, Ifelodun, Oke-Ero, Oyun, Moro, Offa, Isin, Patigi, Asa, Edu, 
and Ekiti. Informed consent was obtained from each PMV, and 
confidentiality of personal information was assured. No harm was 
inflicted on participants as a result of participating in this study. 
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Study design 
We conducted a quasi-experimental, before-and-after the IPC 
training which was held at the Pharmacists’ House, Kwara Hotels, 
Ilorin, Kwara state in September, 2020. All participants were 
included, and questionnaires with missing fields were excluded from 
this study. Resource persons included COVID-19 response team 
members in Kwara state who had participated in a trainers’ training 
regarding the management of the COVID-19 outbreak. The training 
agenda and materials provided by the Nigeria Center for Disease 
Control (NCDC) were adapted for this study. The training consisted 
of didactic lectures, interactive sessions, and role-plays. We obtained 
information on participants’ sociodemographic characteristics, years 
of experience, the average number of customers, the highest level of 
education, years of practice, and whether IPC training had been 
received previously. We conducted pre-and post-tests using 
questions covering the training topics.  
Training topics 
The training topics were divided into 5 sections. The first topic, Basics 
of COVID-19, included lessons on the history of Coronaviruses, 
definition and emergence of COVID-19, modes of transmission, COVID-
19 risk factors, COVID-19 vulnerable population, such as the elderly 
and persons with underlying health conditions e. g. diabetes, and an 
overview of recommended guidelines for self-protection from COVID-
19, such as social distancing.  
The second topic, “Standard infection prevention and control (IPC) 
precautions”, included measures for the prevention and control of 
COVID-19. The IPC precautions taught included the use of face 
masks and gloves and disinfection of surfaces and the environment. 
The practice of hand hygiene should be maintained prior to the use 
of any personal protective equipment (PPE) was reiterated in many 
instances. The PMV was taught the appropriate method for donning 
and doffing of face masks and gloves, and the avoidance of contact 
with the outward surface of both face masks and gloves. Also, 
lessons were taught on covering the bridge of the nose and the chin 
respectively with the upper and lower ends of the face mask. 
The third topic, “Demonstration of the 5 moments of hand hygiene,” 
entailed observing hand hygiene before touching a suspected or 
positive case of COVID-19, before conducting clean/aseptic 
procedures, after exposure to the risk of body fluid, after touching a 
suspected or positive case of COVID-19, and after touching the 
surrounding of such individuals. The appropriate modalities for 
practicing hand hygiene using either soap and clean water or 
alcohol-based hand rubs were also demonstrated. The hand rubs are 
to be prepared with 70% alcohol content for effective cleanliness. 
After each session of handwashing with soap and water, the hands 
should be dried using disposable napkins or tissue papers. 
The fourth topic, “Management of healthcare waste generated,” 
included the method of disposing of used PPE after each use. Such 
wastes generated should be handled as infectious wastes and 
properly discarded in tight-fitted thrash bins to rule out the 
possibility of being picked by children in the community. Recycling 
of face masks could also be done through washing them in a chlorine 
solution after each use. 
The fifth topic, “Detailed knowledge of the COVID-19 outbreak 
response in Kwara state” described the COVID-19 situation in Kwara 
state, including information on the hot-spot communities within the 
state. It also included lessons on the outbreak response team, and 
notification officers for suspected cases of COVID-19.  
Data collection, management, and analysis 
We analyzed the data using SPSS, version 23. Overall, eight 
questions were asked, and each question was assigned a score of “1” 
for correct responses. We computed participants’ scores at the pre-
and post-tests, as well as the mean, median, and the range of scores 
obtained. A maximum obtainable score of 100% was calculated 
using the aggregate scores. Participants who had scored<50% were 
categorized as “Fail”, while those with scores ≥50% were 
categorized as “Pass” in both the pre and post-tests. The Chi-square 
test was used to test for the difference between the proportion of 
study participants who had passed both the pre and post-tests. In 
addition, we used the paired t-test to test for significant differences 
between the pre and post-tests mean scores. We also assessed the 
association between sociodemographic characteristics and pre and 
post-tests knowledge scores. The level of significance was set at 
p<0.05 for all statistical tests.  
RESULTS 
Table 1 shows the sociodemographic characteristics of patent 
medicine vendors. The mean age of the 1076 respondents was 
37.06±10.96. Among them, 348 (32.3%) were males, 295 (27.4%) 
were below 30 y, 364 (36.5%) had spent more than 10 y in practice 
as patent medicine vendors. Among them, 298 (27.7%) had received 
previous IPC training (table 1). Also, 97(9.0%) were from Ilorin 
South, 95(8.8%) from Ilorin East, 90(8.4%) from Irepodun, and 
89(8.3%) were from Ilorin West LGAs (fig. 1). 
 
Table 1: Sociodemographic characteristics of patent medicine vendors 
Variable Frequency % 
Sex   
Male 348 32.3 
Female 728 67.7 
Age group (years)   
<30 295 27.4 
30-39 370 34.4 
40-49 234 21.7 
≥50 177 16.4 
Highest level of education   
Secondary 639 59.4 
Tertiary 437 40.6 
Years of Practice    
≤10 712 66.2 
>10 364 33.8 
Average daily customers   
≤15 556 51.7 
>15 520 48.3 
Received previous IPC training?   
Yes 298 27.7 
No 778 72.3 
 
Among the PMV, 166 (47.7%) males passed the pre-test compared 
to 297 (40.8%) females (X2=4.579, p<0.032), while 138 (39.7%) 
males passed the post-test compared to 321 (44.4%) females 
(X2=1.896, p=0.169), though the difference was not significant 
statistically. Also, 116 (39.3%) of respondents below 30 y passed the 
pre-test compared to other age groups (X2=6.831, p=0.033), and 156 
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(52.9%) passed the post-test (X2=12.476, p=0.002). Further, 254 
(39.7%) respondents with secondary education passed the pre-test 
compared to 209 (47.8%) with tertiary education (X2=6.906, 
p=0.009), and 348 (54.5%) with secondary education passed the 
post-test compared to 269 (61.6%) with tertiary education 
(X2
 
=5.342, p=0.021) (table 2). 
 
Fig. 1: Geographical distribution of patent medicine vendors at the IPC training program 
 
Table 2: Association between sociodemographic characteristics and performance of patent medicine vendors in the pre-and post-IPC 
training results 
Characteristics Pre-test Post-test 
Pass n (%) Fail n (%) Pass n (%) Fail n (%) 
Sex     
Male 166(47.7) 182(52.3) 210(60.3) 138(39.7) 
Female 297(40.8) 431(59.2) 407(55.9) 321(44.4) 
 X2 X=4.579 p=0.032 2
Age Group (years) 
=1.896 p=0.169 
    
<30 116(39.3) 179(60.7) 156(52.9) 139(47.1) 
30-49 256(42.4) 348(57.6) 339(56.1) 265(43.9) 
≥50 91(51.4) 86(48.6) 122(68.9) 55(31.1) 
 X2 X=6.831 p=0.033 2
Highest level of education 
=12.476 p=0.002 
    
Secondary 254(39.7) 385(60.3) 348(54.5) 291(45.5) 
Tertiary 209(47.8) 228(52.2) 269(61.6) 168(38.4) 
 X2 X=6.906 p=0.009 2
Years of Practice 
=5.342 p=0.021 
    
≤10 282(39.6) 430(60.4) 399(56) 313(44) 
>10 181(49.7) 183(50.3) 218(59.9) 146(40.1) 
 X2 X=10.060 p=0.002 2
Average daily customers* 
=0.121 p=0.728 
    
≤15 214(38.5) 312(61.5) 316(56.8) 240(43.2) 
>15 249(47.9) 271(52.1) 301(57.9) 219(42.1) 
 X2 X=9.676 p=0.002 2
Had previous IPC training 
=4.579 p=0.032 
    
Yes 127(42.6) 171(57.4) 164(55) 134(45) 
No 336(43.2) 442(56.8) 453(58.2) 325(41.8) 
 X2 X=0.029 p=0.866 2=0.898 p=0.343 
Among the respondents, 463(43%) passed the pre-test, while 617 (57.3%) passed the post-test. The mean pre-test IPC training score was 
3.1310±1.5631, while the mean post-test IPC training score was 3.7351±1.6028 (t=-11.337, p=<0.001). In all, 617(57.3%) scored higher in posttest. 
A weak positive correlation was found between the pre-and post-IPC training test scores (r=0.328, p=<0.001, N=1076) (table 3). 
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Among the respondents, 606 (56.3%) identified that patent 
medicine vendors had roles to play in the prevention of COVID-19. 
Of the 606 responses obtained in this regard, 560 (92.41%) 
identified community sensitization and health education on COVID-
19 preventive measures as roles of PMV. Also, 46 (7.59%) stated the 
roles of patent medicine vendors in the COVID-19 outbreak to 
include active case search and linking of community members to 
COVID-19 testing and care. 
  
Table 3: Results of COVID-19 IPC training among patent medicine vendors in Kwara state 
Respondents’ performance Pre-test n (%) Post-test n (%) Test-statistic; p-value 
Pass 463(43) 617(57.3) X2= 44.062; p=<0.001 
Fail 613(57) 459(32.7)  
mean±SD 3.1310±1.5631 (68.1) 3.7351±1.6028 (57.3) t=-11.337; p=<0.001 
Median 3.00 4.00  
Range 0-7 0-8  
 
DISCUSSION 
We found a significant association between the age group of PMV 
and the IPC training pre-test and post-test performance. Individuals 
in the older age group performed better than their counterparts in 
the younger age group in both pre and post-test scores. This finding, 
therefore, highlights an increased likelihood for acquiring 
knowledge with increasing age. Similarly, as the years of PMV 
increase, so does the number of years spent in practice and likewise 
the average number of daily customers. An increase in the number 
of customers had significant effects on the pre and post-tests scores. 
This finding suggests that the average daily customers attended to 
results to an increase in the knowledge of PMV, which is primarily 
due to numerous customer-PMV attendant interactions regarding 
various illnesses. In addition, attainment of a higher level of 
education similarly increased the pre and post-test performance. 
Such improvement stems from patient satisfaction, which results in 
an increased number of daily customers. This finding is akin to the 
reports from other studies [12, 13]. The consonance between the 
findings in this study and reference literature reiterate that 
increasing average customers results to an increasing stock of 
medications in patent medicine stores, and ultimately an increased 
opportunity for patients’ care.  
We identified certain roles to be played by PMV during the COVID-
19 pandemic. The effective engagement of PMV in any health 
response is largely determined by the identification of their 
potential roles [12]. We found that community sensitization is a key 
role to be conducted by PMV. This is because PMV could build on 
their adequate understanding of community members and the 
terrain to mobilize stakeholders for health education regarding 
COVID-19. The involvement of PMV and other professionals have 
been described as laudable efforts for the prevention of COVID-
19[18]. In this regard, trainings on the structure, content, and 
modalities for delivering health education and public health 
campaigns need to be conducted for PMV. Also, scheduled regular 
evaluation of trainings need to be conducted to keep PMV abreast of 
their roles on the health education of community members. 
In addition, PMV could serve as focal persons to conduct an active case 
search of suspected COVID-19 cases. Due to the existing relationship 
between PMV and community members, PMV could suitably function 
as COVID-19 case notification officers to enable timely detection of 
COVID-19 cases, and limit further transmission of COVID-19 among 
community members. In addition, the active engagement of PMV who 
residents of the communities are often where they practice fosters the 
trust of other community members in the COVID-19 containment 
efforts currently implemented by the government. Linkage of 
community members to COVID-19 testing centers could then be 
possible in such a manner as to reduce the inherent inequalities in 
accessing care in the Nigerian health system. Evidence of the feats 
done through the active engagement of PMV has been demonstrated in 
events of malaria treatment, effective management of diarrhea, and 
increased uptake of health insurance[10,19,20]. Therefore, PMV 
should be appropriately harnessed as a vital human resource for the 
prevention and control of COVID-19. 
STRENGTHS 
The training was conducted by seasoned resource persons, and the 
NCDC guidelines were made use of.  
LIMITATIONS 
The limited period within which the training was conducted could 
have limited the knowledge of the PMV who attended the training. 
All the 16 LGAs in Kwara state were not represented by the PMV in 
attendance at the IPC training. This could, therefore prevent the 
generalizability of the results obtained in this study. 
CONCLUSION 
The IPC had much relevance at the period it was conducted. 
Improvement of knowledge was observed after the IPC training 
among PMV. Trainings on COVID-19 preventive practices among 
PMV should not be a one-off event. Rather, repeat sessions of such 
trainings should be organized to keep PMV abreast of current 
protocols needed to prevent COVID-19. Also, modalities for the 
scheduled evaluation of knowledge gained from such trainings 
should be developed through PMV association. Also, PMV should be 
empowered to sensitize and educate their clients on the prevention 
of COVID-19 and link them to testing when required. 
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